Home » Topics » Regulatory » Patents

Patents
RSS

Roche presents novel pyrrolodine aryl-ether compounds

March 24, 2009

Vertex Pharmaceuticals claims novel protein kinase inhibitors

March 24, 2009

Allergan reports novel pyrrole compounds for the treatment of glaucoma

March 24, 2009

Merck Frosst Canada presents novel renin inhibitors

March 24, 2009

Novel imidazopyrazine compounds discovered by BioFocus

March 23, 2009

Novel cannabinoid 2 receptor agonists reported by Merck & Co.

March 23, 2009

Novel naphthalene derivatives patented by Servier

March 23, 2009

Valeant Pharmaceuticals International presents novel potassium channel modulators

March 23, 2009

Novartis patents novel beta-secretase inhibitors

March 20, 2009

Novel heterocyclic compounds developed by Merck & Co. for the treatment of diabetes

March 20, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.